Stock CTBO CANTABIO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Cantabio Pharmaceuticals, Inc.

Equities

CTBO

US13808X2036

Market Closed - OTC Markets
Other stock markets
 02:08:59 2021-08-19 pm EDT 		5-day change 1st Jan Change
1.01 USD -95.96% Intraday chart for Cantabio Pharmaceuticals, Inc. -.--% -.--%
2019 Cantabio Pharmaceuticals and Luxembourg Institute of Health Collaborate Researches the Therapeutic targeting of the DJ 1 Protein to Treat Immune Associated Diseases CI
2019 Cantabio Pharmaceuticals Inc. will Change its Ticker to CTBO from CTBOD CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CANTABIO PHARMACEUTICALS, INC. Stock Cantabio Pharmaceuticals, Inc.
 24.35K - - - - -
MODERNA, INC. Stock Moderna, Inc.
 45.34B -
LONZA GROUP AG Stock Lonza Group AG
 40.42B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 37.92B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 31.75B -
CELLTRION, INC. Stock Celltrion, Inc.
 27.71B
  1. Stock Market
  2. Equities
  3. CTBO Stock
  4. Charts Cantabio Pharmaceuticals, Inc.
  5. Sector Chart